Jugdutt B I, Khan M I, Jugdutt S J, Blinston G E
Department of Medicine, University of Alberta, Edmonton, Canada.
Circulation. 1995 Aug 15;92(4):926-34. doi: 10.1161/01.cir.92.4.926.
Late reperfusion during acute myocardial infarction results in delayed recovery of ventricular function and less remodeling, whereas ventricular unloading with nitrates improves function and attenuates remodeling. Whether late reperfusion combined with prolonged unloading with isosorbide-5-mononitrate (ISMN) might produce greater functional recovery and less remodeling than late reperfusion alone is not known.
In vivo left ventricular function and topography (echocardiograms), postmortem topography (planimetry), and collagen (hydroxyproline) were measured in dogs that were randomized to reperfusion 2 hours after left anterior descending coronary artery ligation, and ISMN (n = 12) or placebo (n = 12) was given as 25 mg IV over 4 hours followed by 50 mg PO QID for 6 weeks. Compared with placebo, the ISMN group had similar heart rate but lower left atrial pressure, mean arterial pressure, and rate-pressure products. Although in vivo baseline remodeling and functional parameters were similar in the two groups, by 6 weeks the ISMN group had smaller (P < or = .05) infarct and noninfarct segment lengths, ventricular volumes, and mass; less (P < .001) asynergy; and greater (P < .001) ejection fraction. More important, by 2 days, ejection fraction was 18% greater (P < .025) and asynergy 26% less (P < .05) with ISMN. At 6 weeks, ISMN showed less (P < or = .05) scar size, scar collagen, cavity dilation, noninfarct wall thickness, and apical bulging than placebo. In another 4 dogs, acute ISMN produced less improvement in function and remodeling than prolonged ISMN.
Late reperfusion of acute anterior myocardial infarction combined with prolonged ISMN unloading results in greater and earlier recovery of ventricular function and less remodeling than late reperfusion alone.
急性心肌梗死期间的晚期再灌注可导致心室功能延迟恢复和较少的重塑,而使用硝酸盐进行心室减负可改善功能并减轻重塑。晚期再灌注联合5-单硝酸异山梨酯(ISMN)长时间减负是否比单纯晚期再灌注能产生更大的功能恢复和更少的重塑尚不清楚。
对随机分为在左冠状动脉前降支结扎2小时后进行再灌注的犬进行体内左心室功能和形态学(超声心动图)、死后形态学(平面测量)以及胶原蛋白(羟脯氨酸)的测量,12只犬静脉注射25mg ISMN或安慰剂,持续4小时,随后口服50mg,每日4次,共6周。与安慰剂组相比,ISMN组心率相似,但左心房压力、平均动脉压和心率-压力乘积较低。尽管两组体内基线重塑和功能参数相似,但到6周时,ISMN组梗死和非梗死节段长度、心室容积和质量较小(P≤0.05);协同失调较少(P<0.001);射血分数较高(P<0.001)。更重要的是,到2天时,ISMN组射血分数高18%(P<0.025),协同失调少26%(P<0.05)。在6周时,与安慰剂相比,ISMN组瘢痕大小、瘢痕胶原蛋白、腔扩张、非梗死壁厚和心尖膨出较少(P≤0.05)。在另外4只犬中,急性ISMN在功能和重塑方面的改善比长时间ISMN少。
急性前壁心肌梗死的晚期再灌注联合长时间ISMN减负比单纯晚期再灌注能导致更大且更早的心室功能恢复和更少的重塑。